Low-Level Cigarette Smoking and Longitudinal Change in Serum Cholesterol Among Adolescents
The Berlin-Bremen Study
- James H. Dwyer, PhD;
- Gudrun E. Rieger-Ndakorerwa, MD;
- Norbert K. Semmer, PhD;
- Reinhard Fuchs, DipPsy;
- Peter Lippert, MD
- From the Institute for Health Promotion and Disease Prevention Research, Department of Preventive Medicine, University of Southern California School of Medicine, Pasadena (Dr Dwyer); State Health Administration, Hamburg, West Germany (Drs Rieger-Ndakorerwa and Lippert); University of Bern (Switzerland) (Dr Semmer); and Department of Psychology, Free University of Berlin, Berlin (West) (Mr Fuchs).
Abstract
The current study was conducted to determine if smokers and nonsmokers differ in serum concentrations of high-density lipoprotein cholesterol (HDL-C) before smoking initiation and if a decline in HDL-C levels could be detected among adolescents during the first two years of smoking. Changes in HDL-C levels and smoking were observed longitudinally in 1983, 1984, and 1985 among 691 seventh and eighth graders (age range, 12 to 14 years) from two German cities; 82% were nonsmokers at baseline. For these baseline nonsmokers, no differences in baseline HDL-C concentrations were found between those who became smokers and those who remained nonsmokers. In contrast, those who became light (one to 39 cigarettes per week) or moderate (≥40 cigarettes per week) smokers by one or two years after the initial examination evidenced lower mean HDL-C concentrations relative to persistent nonsmokers at follow-up, constituting a decrement of −0.016 mmol/L [SE=.035] (−0.6 mg/dL) [SE=1.4] for light smokers and −0.114 mmol/L [SE=.064] (−4.4 mg/dL) [SE=2.5] for moderate smokers. These findings suggest that short-term exposure to cigarette smoke at low levels may have atherogenic consequences.
(JAMA 1988;259:2857-2862)
Footnotes
-
Read before the annual meeting of the Epidemiology Council of the American Heart Association, San Francisco, March 23,1986.
-
Reprint requests to Institute for Health Promotion and Disease Prevention Research, 35 N Lake Ave, Suite 200, Pasadena, CA91101 (Dr Dwyer).








